An IMPACT study specimen collection kit is seen in Chatham, New Jersey
A specimen collection kit mailed in September 2021 to patients with blood cancers enrolled in the IMPACT study (Immune Profiling with Antibody-based COVID-19 Testing), being conducted by the Dana Farber Cancer Institute and Quest Diagnostics to shed light on how these patients' immune systems may interact with the SARS-CoV-2 virus or the vaccines, is seen in Chatham, New Jersey, U.S. September 10, 2021. REUTERS/Nancy Lapid